StudyRareStudyRare

Neural Crest & Neurocristopathies

Log in to star

Last updated 2mo ago

Log in to add personal notes on this page.

Neural crest cells delaminate from the dorsal lips of the closing neural tube during week 4, undergo an epithelial-to-mesenchymal transition (EMT), and migrate throughout the embryo to populate an astonishingly wide range of structures. Because so many disparate tissues share this single origin, a defect in neural-crest specification, migration, or survival produces seemingly unrelated phenotypes that share an embryologic mechanism: the neurocristopathies. Recognizing the neural-crest signature behind a syndrome is one of the most useful conceptual moves in dysmorphology.

RegionDerivatives
Cranial neural crestCraniofacial bone and cartilage, dentin, parafollicular C-cells of thyroid (via 4th pouch), ciliary muscle, corneal stroma
Cardiac neural crestAorticopulmonary septum, conotruncal patterning, smooth muscle of great vessels
Vagal/sacral neural crestEnteric nervous system (myenteric and submucosal plexuses)
Trunk neural crestDorsal root ganglia, sympathetic chain, adrenal medulla (chromaffin cells), Schwann cells, melanocytes

The phrase "the fourth germ layer" is shorthand for the breadth of neural-crest contributions. Tracing a phenotype to the crest is often the trick.

  • Dorsolateral pathway: between somite and overlying ectoderm; gives melanocytes.
  • Ventrolateral pathway: between somite and neural tube; gives dorsal root ganglia, sympathetic chain, adrenal medulla, Schwann cells.
  • Cranial-caudal cranial migration: pharyngeal arches and craniofacial mesenchyme.

Migration is guided by EphrinB / EphB repulsion (preventing rostral migration through caudal sclerotome halves) and by chemokines along the path.

Hirschsprung disease (aganglionic megacolon)

  • Mechanism: vagal/sacral neural-crest cells fail to colonize the distal gut, producing aganglionosis (absence of Meissner's and Auerbach's plexuses) starting at the anus and extending proximally a variable distance.
  • Genetics: RET (most common; ~50% familial cases), EDNRB, EDN3, GDNF, SOX10. Most cases are sporadic with multifactorial inheritance.
  • Phenotype: failure to pass meconium in 48 h, bilious vomiting, distended abdomen. Rectal biopsy shows absent ganglia and hypertrophic acetylcholinesterase-positive nerves.
  • Associations: ~10% have Down syndrome; multiple-endocrine-neoplasia type 2 (MEN2A/B) shares RET pathology (same gene, different mutations, opposite effects: loss-of-function → Hirschsprung; gain-of-function → MEN2).

Waardenburg syndrome

  • Mechanism: melanocyte and other neural-crest cell specification/migration failure.
  • Genetics: PAX3 (types 1, 3), MITF (type 2), SOX10 (type 4), EDN3/EDNRB (type 4 with Hirschsprung).
  • Phenotype: sensorineural deafness (cochlear melanocyte loss), white forelock, heterochromia iridis, dystopia canthorum (type 1). Type 4 includes Hirschsprung (same SOX10/EDNRB axis).

CHARGE syndrome

  • Mechanism: CHD7 mutation disrupts neural-crest gene expression broadly.
  • Phenotype: Coloboma, Heart defects (often conotruncal), Atresia of choanae, Retardation of growth/development, Genital hypoplasia, Ear anomalies (deafness).
  • Genetics: heterozygous CHD7 mutations; usually de novo, autosomal dominant.

22q11.2 deletion syndrome (DiGeorge / VCFS)

  • Mechanism: cardiac neural-crest contribution to the aorticopulmonary septum and 3rd/4th pharyngeal pouch derivatives is disrupted by haploinsufficiency of TBX1 within the deleted region.
  • Phenotype: conotruncal heart defects (truncus arteriosus, interrupted aortic arch type B, tetralogy of Fallot), thymic hypoplasia (T-cell immunodeficiency), hypocalcemia (parathyroid hypoplasia), velopharyngeal insufficiency, characteristic facies.

Treacher Collins syndrome

  • Mechanism: TCOF1 (treacle), POLR1C, POLR1D mutations disrupt rRNA biogenesis specifically in cranial neural-crest cells, causing apoptosis. Note: this is a defect of crest survival, not migration.
  • Phenotype: bilateral malar/mandibular hypoplasia, downslanting palpebral fissures, lower-lid coloboma, microtia/external ear anomalies; conductive hearing loss. Normal intelligence.

Neurofibromatosis type 1 (NF1)

  • Mechanism: NF1 mutation causes loss of neurofibromin (a Ras-GAP) in Schwann cells (neural-crest-derived) and melanocytes. Tumors arise in crest-derived tissues.
  • Phenotype: café-au-lait macules, axillary/inguinal freckling, neurofibromas, optic glioma, Lisch nodules (iris hamartomas), bony dysplasia.

Sacrococcygeal teratoma

  • Mechanism: persistence of pluripotent cells from Hensen's node / primitive streak; classified as germ-cell tumor but arises in the same caudal region neural crest passes through.
  • Phenotype: most common neonatal tumor; large, often with all three germ-layer tissues. Maternal AFP often elevated.
FailureResulting syndrome / finding
Cardiac NC → aorticopulmonary septum22q11.2 conotruncal lesions; persistent truncus arteriosus
Vagal NC → enteric gangliaHirschsprung disease
Melanocyte specificationWaardenburg, piebaldism
Cranial NC apoptosis (rRNA defect)Treacher Collins
Schwann cell tumor suppressionNF1
Broad CHD7-mediated patterningCHARGE
Crest contribution to outflow + thymus + parathyroidDiGeorge

"MOTEL PASS": neural-crest derivatives. Melanocytes, Odontoblasts, Tympanic ossicles (malleus/incus, arch-1 and arch-2 cartilage), Enterochromaffin cells (and ENS), Laryngeal cartilage, Parafollicular C-cells, Adrenal medulla, Schwann cells, Spiral membrane (cochlea).

"RET cuts both ways": loss-of-function → Hirschsprung; gain-of-function → MEN2.

  • Conotruncal heart defect + thymic/parathyroid problems → 22q11.2 (cardiac neural crest).
  • Aganglionic distal colon with failure to pass meconium → Hirschsprung; check RET.
  • Sensorineural deafness + pigmentary anomaly (white forelock, heterochromia) → Waardenburg.
  • Neural crest is "the fourth germ layer." When a syndrome combines anatomically unrelated structures (face + heart + gut + skin pigment), think neurocristopathy.
  • Hirschsprung is more common in Down syndrome (~5–10× baseline rate). Always include in the differential for delayed meconium in trisomy 21.